Bills
HR 5160 — Stem Cell Therapeutic and Research Reauthorization Act of 2025
HR 5160 is a measure before Congress. This page is what Rallybase holds about it and the date each part of it was read.
Its source has published no summary of it that Rallybase holds, and Rallybase prints none it cannot attribute to a source and a date.
As of 2026-07-23, the source's own latest action on it read: "Received in the Senate. Read twice. Placed on Senate Legislative".
- Identifier
- HR 5160
- Level
- Federal
- Jurisdiction
- the United States
- Session
- 119
- Chamber, from the bill number
- House of Representatives
- Where that identifier comes from
- Congress 119 — from the bill's congress.gov identifier.
- Latest action, as the source published it
- Received in the Senate. Read twice. Placed on Senate Legislative
- Read on
What you can do from here
- Write about this billYou write the letter; sending it yourself is free
- Every bill Rallybase is tracking
What Rallybase does not know here
- Who sponsored it. The sync that loads these rows does not carry a sponsor.
- How anybody voted on it. Rallybase has not read roll calls for this body, which is our coverage that is empty and not a statement about whether a vote was held.
- When it is next scheduled to be taken up.
Other bills before Congress
- HR 5174 — To make revisions in title 51, United States Code, as necessary to keep the title current, and to make technical amendments to improve the United States Code.
- HR 5182 — To make improvements in the enactment of title 54, United States Code, into a positive law title and to correct related technical errors.
- HR 5185 — To make improvements in the enactment of title 41, United States Code, into a positive law title and to improve the Code.